Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD

Abstract Cases of myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) co‐occurring with neoplasms have been reported. In this international, retrospective cohort study in South Korea and the USA, 16 of 445 (3.6%) patients with MOGAD had concurrent neoplasm within 2 years of...

Full description

Saved in:
Bibliographic Details
Main Authors: Young Nam Kwon, Nanthaya Tisavipat, Yong Guo, Stephanie B. Syc‐Mazurek, Ji Yeon Han, Jun‐Soon Kim, Kyomin Choi, Seong‐il Oh, Seok‐Jin Choi, Eunhee Sohn, Jeeyoung Oh, Seung Woo Kim, Ha Young Shin, Byung Chan Lim, Byoung Joon Kim, Kyung Seok Park, Jung‐Joon Sung, Se Hoon Kim, Sung‐Hye Park, Anastasia Zekeridou, Claudia F. Lucchinetti, Sean J. Pittock, John J. Chen, Eoin P. Flanagan, Sung‐Min Kim
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.52301
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850171820952518656
author Young Nam Kwon
Nanthaya Tisavipat
Yong Guo
Stephanie B. Syc‐Mazurek
Ji Yeon Han
Jun‐Soon Kim
Kyomin Choi
Seong‐il Oh
Seok‐Jin Choi
Eunhee Sohn
Jeeyoung Oh
Seung Woo Kim
Ha Young Shin
Byung Chan Lim
Byoung Joon Kim
Kyung Seok Park
Jung‐Joon Sung
Se Hoon Kim
Sung‐Hye Park
Anastasia Zekeridou
Claudia F. Lucchinetti
Sean J. Pittock
John J. Chen
Eoin P. Flanagan
Sung‐Min Kim
author_facet Young Nam Kwon
Nanthaya Tisavipat
Yong Guo
Stephanie B. Syc‐Mazurek
Ji Yeon Han
Jun‐Soon Kim
Kyomin Choi
Seong‐il Oh
Seok‐Jin Choi
Eunhee Sohn
Jeeyoung Oh
Seung Woo Kim
Ha Young Shin
Byung Chan Lim
Byoung Joon Kim
Kyung Seok Park
Jung‐Joon Sung
Se Hoon Kim
Sung‐Hye Park
Anastasia Zekeridou
Claudia F. Lucchinetti
Sean J. Pittock
John J. Chen
Eoin P. Flanagan
Sung‐Min Kim
author_sort Young Nam Kwon
collection DOAJ
description Abstract Cases of myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) co‐occurring with neoplasms have been reported. In this international, retrospective cohort study in South Korea and the USA, 16 of 445 (3.6%) patients with MOGAD had concurrent neoplasm within 2 years of MOGAD onset, resulting in a standardized incidence ratio for neoplasm of 3.10 (95% confidence interval [CI], 1.77–4.81; P < 0.001) when compared to the age‐ and country‐adjusted incidence of neoplasm in the general population. However, none of the nine tumor tissues obtained demonstrated MOG immunostaining. The slightly increased frequency without immunohistopathological evidence suggest with true paraneoplastic MOGAD is extremely rare.
format Article
id doaj-art-cbea951b227f429fad4efbd6a16495e3
institution OA Journals
issn 2328-9503
language English
publishDate 2025-04-01
publisher Wiley
record_format Article
series Annals of Clinical and Translational Neurology
spelling doaj-art-cbea951b227f429fad4efbd6a16495e32025-08-20T02:20:12ZengWileyAnnals of Clinical and Translational Neurology2328-95032025-04-0112486187010.1002/acn3.52301Assessment of concurrent neoplasms and a paraneoplastic association in MOGADYoung Nam Kwon0Nanthaya Tisavipat1Yong Guo2Stephanie B. Syc‐Mazurek3Ji Yeon Han4Jun‐Soon Kim5Kyomin Choi6Seong‐il Oh7Seok‐Jin Choi8Eunhee Sohn9Jeeyoung Oh10Seung Woo Kim11Ha Young Shin12Byung Chan Lim13Byoung Joon Kim14Kyung Seok Park15Jung‐Joon Sung16Se Hoon Kim17Sung‐Hye Park18Anastasia Zekeridou19Claudia F. Lucchinetti20Sean J. Pittock21John J. Chen22Eoin P. Flanagan23Sung‐Min Kim24Department of Neurology Severance Hospital, Yonsei University College of Medicine Seoul Republic of KoreaDepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Pediatrics Inha University Hospital Incheon Republic of KoreaDepartment of Neurology Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam Republic of KoreaDepartment of Neurology Soonchunhyang University Cheonan Hospital Cheonan Republic of KoreaDepartment of Neurology Kyung Hee University Hospital, Kyung Hee University College of Medicine Seoul Republic of KoreaDepartment of Neurology Seoul National University Hospital, Seoul National University College of Medicine Seoul Republic of KoreaDepartment of Neurology Chungnam National University College of Medicine, Chungnam National University Hospital Daejeon Republic of KoreaDepartment of Neurology Konkuk University School of Medicine, Konkuk University Medical Center Seoul Republic of KoreaDepartment of Neurology Severance Hospital, Yonsei University College of Medicine Seoul Republic of KoreaDepartment of Neurology Severance Hospital, Yonsei University College of Medicine Seoul Republic of KoreaDepartment of Pediatrics Seoul National University College of Medicine, Seoul National University Children's Hospital Seoul Republic of KoreaDepartment of Neurology Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul Republic of KoreaDepartment of Neurology Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam Republic of KoreaDepartment of Neurology Seoul National University Hospital, Seoul National University College of Medicine Seoul Republic of KoreaDepartment of Pathology Severance Hospital, Yonsei University College of Medicine Seoul Republic of KoreaDepartment of Pathology Seoul National University Hospital, Seoul National University, College of Medicine Seoul Republic of KoreaDepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Neurology Mayo Clinic Rochester Minnesota USADepartment of Neurology Seoul National University Hospital, Seoul National University College of Medicine Seoul Republic of KoreaAbstract Cases of myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) co‐occurring with neoplasms have been reported. In this international, retrospective cohort study in South Korea and the USA, 16 of 445 (3.6%) patients with MOGAD had concurrent neoplasm within 2 years of MOGAD onset, resulting in a standardized incidence ratio for neoplasm of 3.10 (95% confidence interval [CI], 1.77–4.81; P < 0.001) when compared to the age‐ and country‐adjusted incidence of neoplasm in the general population. However, none of the nine tumor tissues obtained demonstrated MOG immunostaining. The slightly increased frequency without immunohistopathological evidence suggest with true paraneoplastic MOGAD is extremely rare.https://doi.org/10.1002/acn3.52301
spellingShingle Young Nam Kwon
Nanthaya Tisavipat
Yong Guo
Stephanie B. Syc‐Mazurek
Ji Yeon Han
Jun‐Soon Kim
Kyomin Choi
Seong‐il Oh
Seok‐Jin Choi
Eunhee Sohn
Jeeyoung Oh
Seung Woo Kim
Ha Young Shin
Byung Chan Lim
Byoung Joon Kim
Kyung Seok Park
Jung‐Joon Sung
Se Hoon Kim
Sung‐Hye Park
Anastasia Zekeridou
Claudia F. Lucchinetti
Sean J. Pittock
John J. Chen
Eoin P. Flanagan
Sung‐Min Kim
Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD
Annals of Clinical and Translational Neurology
title Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD
title_full Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD
title_fullStr Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD
title_full_unstemmed Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD
title_short Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD
title_sort assessment of concurrent neoplasms and a paraneoplastic association in mogad
url https://doi.org/10.1002/acn3.52301
work_keys_str_mv AT youngnamkwon assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT nanthayatisavipat assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT yongguo assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT stephaniebsycmazurek assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT jiyeonhan assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT junsoonkim assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT kyominchoi assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT seongiloh assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT seokjinchoi assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT eunheesohn assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT jeeyoungoh assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT seungwookim assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT hayoungshin assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT byungchanlim assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT byoungjoonkim assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT kyungseokpark assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT jungjoonsung assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT sehoonkim assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT sunghyepark assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT anastasiazekeridou assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT claudiaflucchinetti assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT seanjpittock assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT johnjchen assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT eoinpflanagan assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad
AT sungminkim assessmentofconcurrentneoplasmsandaparaneoplasticassociationinmogad